![\"\"](\"https:\/\/inprojournal.org\/wp-content\/uploads\/2023\/03\/018-cover-734x1024.jpg\")
<\/figure>\n\n\n\nTheory and practice of intellectual property
\u2116 6 \/ 2020<\/p>\n\n\n\n
ISSN (Print) 2308-0361
ISSN (Online) 2519-2744<\/p>\n\n\n\n
![\"\"](\"https:\/\/test.inprojournal.org\/wp-content\/uploads\/2023\/01\/free-icon-pdf-201153.png\"){kind=icon}
PDF (Ukrainian)<\/a><\/div>\n<\/div>\n\n\n\nDOI: https:\/\/doi.org\/10.33731\/62020.233964<\/a><\/p>\n\n\n\n Published \u00a0\u00a0\u00a0\u00a0\u00a02020-12-01<\/p>\n\n\n\n <\/p>\n\n\n\n <\/p>\n<\/div>\n\n\n\n Changing paradigm of supplementary protection of inventions in the national legislation of Ukraine<\/strong><\/p>\n\n\n\n Anastasiia Homeniuk<\/strong> <\/p>\n\n\n\n Abstract Patent term extension in the way it was provided in the Ukrainian Patent Law is a rather simple mechanism that didn\u2019t require much regulations. It used to provide additional period of patent monopolies which was equal to the period which elapsed between the date on which the patent application was filed and the date of the marketing authorisation, not more than 5 years. Since there were no limitation on the type of patent (basic patent) or requirement of the first marketing authorization, this regime provided an opportunity to extend not only basic patent term, but also all secondary patents related to one drug. This created a situation when duration of patent monopoly for one drug exceeded 35 years.<\/p>\n\n\n\n Provided that national pharmaceutical industry is oriented on manufacturing of generic drugs, supplementary protection certificates are more appropriate for Ukraine. Firstly, this is due to the limitation of effective patent life to 15 years which is more feasible considering the national context. Another positive thing about SPCs is some uncertainty in relation to definition of the subject matter and scope of SPC protection. That means that the country can have some freedom in determining the ways of its interpretation. However, it should be noted that such indeterminacy is a grey zone. Thus, it is necessary to consider how the country can benefit from the supplementary protection regimen. Since the pharmaceutical sphere is very sensitive, the SPC issues have direct effect on public health and access to treatment. So, the article justifies the general idea that implementation of new legislation provisions shall be aligned with both ensuring pharmaceutical innovations and guaranteeing that the public health needs are still a priority. Therefore, considering the long-term negative effect of the patent term extension regimen, the new SPC approach should be as balanced as possible.<\/p>\n\n\n\n Keywords: <\/strong>patent term extension, supplementary protection, supplementary protection certificate, drug patents, patent legislation reform<\/p>\n\n\n\n References<\/strong><\/p>\n\n\n\n \u041f\u0440\u043e \u0432\u043d\u0435\u0441\u0435\u043d\u043d\u044f \u0437\u043c\u0456\u043d \u0434\u043e \u0434\u0435\u044f\u043a\u0438\u0445 \u0437\u0430\u043a\u043e\u043d\u043e\u0434\u0430\u0432\u0447\u0438\u0445 \u0430\u043a\u0442\u0456\u0432 \u0423\u043a\u0440\u0430\u0457\u043d\u0438 \u0449\u043e\u0434\u043e \u0440\u0435\u0444\u043e\u0440\u043c\u0438 \u043f\u0430\u0442\u0435\u043d\u0442\u043d\u043e\u0433\u043e \u0437\u0430\u043a\u043e\u043d\u043e\u0434\u0430\u0432\u0441\u0442\u0432\u0430 : \u0417\u0430\u043a\u043e\u043d \u0423\u043a\u0440\u0430\u0457\u043d\u0438 \u0432\u0456\u0434 21.07.2020 \u0440. \u2116 816-IX. \u041f\u0440\u043e \u043e\u0445\u043e\u0440\u043e\u043d\u0443 \u043f\u0440\u0430\u0432 \u043d\u0430 \u0432\u0438\u043d\u0430\u0445\u043e\u0434\u0438 \u0456 \u043a\u043e\u0440\u0438\u0441\u043d\u0456 \u043c\u043e\u0434\u0435\u043b\u0456 : \u0417\u0430\u043a\u043e\u043d \u0423\u043a\u0440\u0430\u0457\u043d\u0438 \u0432\u0456\u0434 15.12.1993 \u0440. \u2116\u20083687-XII. \u041f\u0440\u043e \u0437\u0430\u0442\u0432\u0435\u0440\u0434\u0436\u0435\u043d\u043d\u044f \u0406\u043d\u0441\u0442\u0440\u0443\u043a\u0446\u0456\u0457 \u043f\u0440\u043e \u043f\u043e\u0440\u044f\u0434\u043e\u043a \u043f\u0440\u043e\u0434\u043e\u0432\u0436\u0435\u043d\u043d\u044f \u0441\u0442\u0440\u043e\u043a\u0443 \u0434\u0456\u0457 \u043f\u0430\u0442\u0435\u043d\u0442\u0443 \u043d\u0430 \u0432\u0438\u043d\u0430\u0445\u0456\u0434, \u043e\u0431\u02bc\u0454\u043a\u0442\u043e\u043c \u044f\u043a\u043e\u0433\u043e \u0454 \u0437\u0430\u0441\u0456\u0431, \u0432\u0438\u043a\u043e\u0440\u0438\u0441\u0442\u0430\u043d\u043d\u044f \u044f\u043a\u043e\u0433\u043e \u043f\u043e\u0442\u0440\u0435\u0431\u0443\u0454 \u0434\u043e\u0437\u0432\u043e\u043b\u0443 \u043a\u043e\u043c\u043f\u0435\u0442\u0435\u043d\u0442\u043d\u043e\u0433\u043e \u043e\u0440\u0433\u0430\u043d\u0443 : \u043d\u0430\u043a\u0430\u0437 \u041c\u0456\u043d\u0456\u0441\u0442\u0435\u0440\u0441\u0442\u0432\u0430 \u043e\u0441\u0432\u0456\u0442\u0438 \u0456 \u043d\u0430\u0443\u043a\u0438 \u0423\u043a\u0440\u0430\u0457\u043d\u0438 \u0432\u0456\u0434 13.05.2002 \u2116 298. \u0423\u0433\u043e\u0434\u0430 \u043f\u0440\u043e \u0430\u0441\u043e\u0446\u0456\u0430\u0446\u0456\u044e \u043c\u0456\u0436 \u0423\u043a\u0440\u0430\u0457\u043d\u043e\u044e, \u0437 \u043e\u0434\u043d\u0456\u0454\u0457 \u0441\u0442\u043e\u0440\u043e\u043d\u0438, \u0442\u0430 \u0404\u0432\u0440\u043e\u043f\u0435\u0439\u0441\u044c\u043a\u0438\u043c \u0421\u043e\u044e\u0437\u043e\u043c, \u0404\u0432\u0440\u043e\u043f\u0435\u0439\u0441\u044c\u043a\u0438\u043c \u0441\u043f\u0456\u0432\u0442\u043e\u0432\u0430\u0440\u0438\u0441\u0442\u0432\u043e\u043c \u0437 \u0430\u0442\u043e\u043c\u043d\u043e\u0457 \u0435\u043d\u0435\u0440\u0433\u0456\u0457 \u0456 \u0457\u0445\u043d\u0456\u043c\u0438 \u0434\u0435\u0440\u0436\u0430\u0432\u0430\u043c\u0438-\u0447\u043b\u0435\u043d\u0430\u043c\u0438, \u0437 \u0456\u043d\u0448\u043e\u0457 \u0441\u0442\u043e\u0440\u043e\u043d\u0438. \u0428\u0442\u0435\u0444\u0430\u043d \u0410. \u0414\u0435\u044f\u043a\u0456 \u043f\u0440\u043e\u0431\u043b\u0435\u043c\u0438 \u0437\u0430\u0441\u0442\u043e\u0441\u0443\u0432\u0430\u043d\u043d\u044f \u0423\u0433\u043e\u0434\u0438 \u043f\u0440\u043e \u0430\u0441\u043e\u0446\u0456\u0430\u0446\u0456\u044e \u044f\u043a \u0434\u0436\u0435\u0440\u0435\u043b\u0430 \u0430\u0432\u0442\u043e\u0440\u0441\u044c\u043a\u043e\u0433\u043e \u043f\u0440\u0430\u0432\u0430 \u0423\u043a\u0440\u0430\u0457\u043d\u0438. \u0422\u0435\u043e\u0440\u0456\u044f \u0456 \u043f\u0440\u0430\u043a\u0442\u0438\u043a\u0430 \u0456\u043d\u0442\u0435\u043b\u0435\u043a\u0442\u0443\u0430\u043b\u044c\u043d\u043e\u0457 \u0432\u043b\u0430\u0441\u043d\u043e\u0441\u0442\u0456. 2019. \u2116 1. \u0421. 5\u221216.<\/p>\n\n\n\n \u041a\u0430\u043f\u0456\u0446\u0430 \u042e. \u0421\u0435\u0440\u0442\u0438\u0444\u0456\u043a\u0430\u0442 \u0434\u043e\u0434\u0430\u0442\u043a\u043e\u0432\u043e\u0457 \u043e\u0445\u043e\u0440\u043e\u043d\u0438 \u043b\u0456\u043a\u0430\u0440\u0441\u044c\u043a\u0438\u0445 \u0437\u0430\u0441\u043e\u0431\u0456\u0432 \u0404\u0421 \u0442\u0430 \u043f\u0440\u043e\u0434\u043e\u0432\u0436\u0435\u043d\u043d\u044f \u0441\u0442\u0440\u043e\u043a\u0443 \u0447\u0438\u043d\u043d\u043e\u0441\u0442\u0456 \u043f\u0430\u0442\u0435\u043d\u0442\u0443 \u043d\u0430 \u0432\u0438\u043d\u0430\u0445\u0456\u0434 \u0432 \u0423\u043a\u0440\u0430\u0457\u043d\u0456. \u0422\u0435\u043e\u0440\u0456\u044f \u0456 \u043f\u0440\u0430\u043a\u0442\u0438\u043a\u0430 \u0456\u043d\u0442\u0435\u043b\u0435\u043a\u0442\u0443\u0430\u043b\u044c\u043d\u043e\u0457 \u0432\u043b\u0430\u0441\u043d\u043e\u0441\u0442\u0456. 2016. \u2116 5. \u0421.49\u201356.<\/p>\n\n\n\n \u0410\u043d\u0434\u0440\u043e\u0449\u0443\u043a \u0413. \u041e. \u041f\u0440\u043e\u0431\u043b\u0435\u043c\u0438 \u043f\u0430\u0442\u0435\u043d\u0442\u0443\u0432\u0430\u043d\u043d\u044f \u0432\u0438\u043d\u0430\u0445\u043e\u0434\u0456\u0432 \u0443 \u0444\u0430\u0440\u043c\u0430\u0446\u0435\u0432\u0442\u0438\u0447\u043d\u0456\u0439 \u0433\u0430\u043b\u0443\u0437\u0456: \u0435\u043a\u043e\u043d\u043e\u043c\u0456\u043a\u043e-\u043f\u0440\u0430\u0432\u043e\u0432\u0438\u0439 \u0430\u0441\u043f\u0435\u043a\u0442 (\u0427\u0430\u0441\u0442\u0438\u043d\u0430 \u0406) \/ \u0413. \u041e. \u0410\u043d\u0434\u0440\u043e\u0449\u0443\u043a, \u041b. \u0406. \u0420\u0430\u0431\u043e\u0442\u044f\u0433\u043e\u0432\u0430. \u041d\u0430\u0443\u043a\u0430, \u0442\u0435\u0445\u043d\u043e\u043b\u043e\u0433\u0456\u0457, \u0456\u043d\u043d\u043e\u0432\u0430\u0446\u0456\u0457. 2018. \u2116 4. \u0421. 58\u221267.<\/p>\n\n\n\n Peter Yourkin. Making the Market: How the American Pharmaceutical Industry Transformed itself During the 1940s \/ Peter Yourkin., 2008.<\/p>\n\n\n\n \u0420\u0430\u0431\u043e\u0442\u044f\u0433\u043e\u0432\u0430 \u041b. \u0406. \u041f\u0440\u043e\u0434\u043e\u0432\u0436\u0435\u043d\u043d\u044f \u0441\u0442\u0440\u043e\u043a\u0443 \u0434\u0456\u0457 \u043f\u0430\u0442\u0435\u043d\u0442\u0443 \u043d\u0430 \u0432\u0438\u043d\u0430\u0445\u0456\u0434: \u043c\u0456\u0436\u043d\u0430\u0440\u043e\u0434\u043d\u043e-\u043f\u0440\u0430\u0432\u043e\u0432\u0438\u0439 \u0430\u0441\u043f\u0435\u043a\u0442 \u0440\u0435\u0433\u0443\u043b\u044e\u0432\u0430\u043d\u043d\u044f \/ \u0420\u0430\u0431\u043e\u0442\u044f\u0433\u043e\u0432\u0430 \u041b. \u0406., \u0410\u043d\u0434\u0440\u043e\u0449\u0443\u043a \u0413. \u041e. \u041f\u0438\u0442\u0430\u043d\u043d\u044f \u0456\u043d\u0442\u0435\u043b\u0435\u043a\u0442\u0443\u0430\u043b\u044c\u043d\u043e\u0457 \u0432\u043b\u0430\u0441\u043d\u043e\u0441\u0442\u0456 : \u0437\u0431\u0456\u0440\u043d\u0438\u043a \u043d\u0430\u0443\u043a\u043e\u0432\u0438\u0445 \u043f\u0440\u0430\u0446\u044c. 2018. \u0412\u0438\u043f. 15. \u0421. 89\u2212108.<\/p>\n\n\n\n Council Regulation (EEC) No 1768\/92 of 18 June 1992 concerning the creation of a supplementary protection certificate for medicinal products\/ OJ L 182, 02.07.1992. P. 1\u20135.<\/p>\n\n\n\n Regulation (EC) No 469\/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal products (Codified version)\/ OJ L 152, 16.6.2009, p. 1\u201310.<\/p>\n\n\n\n Scuffi M. Latest case law concerning supplementary protection certificates \/ Massimo Scuffi. \/\/ Official Journal EPO. 2015. \u0421. 105\u2013119.<\/p>\n\n\n\n \u041b\u0456\u0442\u0432\u0456\u043d\u043e\u0432\u0430 \u041e. \u0412. \u0406\u043d\u0442\u0435\u043b\u0435\u043a\u0442\u0443\u0430\u043b\u044c\u043d\u0456 \u0440\u0435\u0441\u0443\u0440\u0441\u0438 \u044f\u043a \u0444\u0430\u043a\u0442\u043e\u0440 \u0456\u043d\u043d\u043e\u0432\u0430\u0446\u0456\u0439\u043d\u043e\u0433\u043e \u0440\u043e\u0437\u0432\u0438\u0442\u043a\u0443 \u0444\u0430\u0440\u043c\u0430\u0446\u0456\u0457 \/ \u041e. \u0412. \u041b\u0456\u0442\u0432\u0456\u043d\u043e\u0432\u0430, \u041e. \u0412. \u041f\u043e\u0441\u0438\u043b\u043a\u0456\u043d\u0430. \u0423\u043f\u0440\u0430\u0432\u043b\u0456\u043d\u043d\u044f, \u0435\u043a\u043e\u043d\u043e\u043c\u0456\u043a\u0430 \u0442\u0430 \u0437\u0430\u0431\u0435\u0437\u043f\u0435\u0447\u0435\u043d\u043d\u044f \u044f\u043a\u043e\u0441\u0442\u0456 \u0432 \u0444\u0430\u0440\u043c\u0430\u0446\u0456\u0457. 2014. \u2116 6. \u0421. 52\u221259.<\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":" Theory and practice of intellectual property\u2116 6 \/ 2020 ISSN (Print) 2308-0361ISSN (Online) 2519-2744 DOI: https:\/\/doi.org\/10.33731\/62020.233964 Published \u00a0\u00a0\u00a0\u00a0\u00a02020-12-01 Changing paradigm of supplementary protection of inventions in the national legislation of Ukraine Anastasiia HomeniukUkrainehttps:\/\/orcid.org\/0000-0002-6431-918X AbstractThe article is mainly aimed at distinguishing two mechanism: patent term extension which used to be applied in Ukraine before the patent […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-9766","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/inprojournal.org\/en\/wp-json\/wp\/v2\/pages\/9766","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/inprojournal.org\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/inprojournal.org\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/inprojournal.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/inprojournal.org\/en\/wp-json\/wp\/v2\/comments?post=9766"}],"version-history":[{"count":3,"href":"https:\/\/inprojournal.org\/en\/wp-json\/wp\/v2\/pages\/9766\/revisions"}],"predecessor-version":[{"id":9769,"href":"https:\/\/inprojournal.org\/en\/wp-json\/wp\/v2\/pages\/9766\/revisions\/9769"}],"wp:attachment":[{"href":"https:\/\/inprojournal.org\/en\/wp-json\/wp\/v2\/media?parent=9766"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}![\"\"](\"https:\/\/inprojournal.org\/wp-content\/uploads\/2025\/11\/CC-2.png\")
<\/figure>\n\n\n\n
Ukraine
https:\/\/orcid.org\/0000-0002-6431-918X<\/a><\/p>\n\n\n\n
<\/strong>The article is mainly aimed at distinguishing two mechanism: patent term extension which used to be applied in Ukraine before the patent reform, and supplementary protection certificates which were introduced to national legislation in 2020.<\/p>\n\n\n\n
https:\/\/zakon.rada.gov.ua\/laws\/show\/816-20#Text<\/a><\/p>\n\n\n\n
https:\/\/zakon.rada.gov.ua\/laws\/show\/3687-12\/ed20200816#Text<\/a><\/p>\n\n\n\n
https:\/\/zakon.rada.gov.ua\/laws\/show\/z0453-02#Text<\/a><\/p>\n\n\n\n
https:\/\/zakon.rada.gov.ua\/laws\/show\/984_011#Text<\/a><\/p>\n\n\n\n